This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1990 Jun;11(6):1066-78.

doi: 10.1002/hep.1840110625.

Liver function and pharmacological considerations in pathogenesis and treatment of portal hypertension

J Reichen¹

Affiliations

PMID: 2194921
DOI: 10.1002/hep.1840110625

Review

Liver function and pharmacological considerations in pathogenesis and treatment of portal hypertension

J Reichen. Hepatology. 1990 Jun.

. 1990 Jun;11(6):1066-78.

doi: 10.1002/hep.1840110625.

Author

J Reichen¹

Affiliation

¹ Department of Clinical Pharmacology, University of Berne, Switzerland.

PMID: 2194921
DOI: 10.1002/hep.1840110625

No abstract available

PubMed Disclaimer

Similar articles

The effect of drugs on the portal circulation.
Reichen J, Lebrec D. Reichen J, et al. J Hepatol. 1987 Oct;5(2):235-40. doi: 10.1016/s0168-8278(87)80579-2. J Hepatol. 1987. PMID: 3320182 Review. No abstract available.
[Vasodilator agents in portal hypertension].
Combis JM, Vinel JP. Combis JM, et al. Gastroenterol Clin Biol. 1991;15(12):881-7. Gastroenterol Clin Biol. 1991. PMID: 1686004 Review. French. No abstract available.
[Vasodilators in portal hypertension].
Ladero Quesada JM. Ladero Quesada JM. An Med Interna. 1994 Apr;11(4):159-61. An Med Interna. 1994. PMID: 8043733 Spanish. No abstract available.
Pharmacologic treatment of portal hypertension.
Rodríguez-Pérez F, Groszmann RJ. Rodríguez-Pérez F, et al. Gastroenterol Clin North Am. 1992 Mar;21(1):15-40. Gastroenterol Clin North Am. 1992. PMID: 1349005 Review.
[New trends in the treatment of hemodynamic disorders in liver cirrhosis].
Vorob'ev LP, Maev IV. Vorob'ev LP, et al. Klin Med (Mosk). 1991 Sep;69(9):11-4. Klin Med (Mosk). 1991. PMID: 1687073 Review. Russian.

See all similar articles

Cited by

Intrahepatic portal occlusion by microspheres: a new model of portal hypertension in the rat.
Jaffe V, Alexander B, Mathie RT. Jaffe V, et al. Gut. 1994 Jun;35(6):815-8. doi: 10.1136/gut.35.6.815. Gut. 1994. PMID: 8020811 Free PMC article.
The portal component of hepatic perfusion measured by dynamic CT: an indicator of hepatic parenchymal damage.
Tsushima Y, Blomley JK, Kusano S, Endo K. Tsushima Y, et al. Dig Dis Sci. 1999 Aug;44(8):1632-8. doi: 10.1023/a:1026679430553. Dig Dis Sci. 1999. PMID: 10492145
Hemodynamic and antifibrotic effects of a selective liver nitric oxide donor V-PYRRO/NO in bile duct ligated rats.
Moal F, Veal N, Vuillemin E, Barrière E, Wang J, Fizanne L, Oberti F, Douay O, Gallois Y, Bonnefont-Rousselot D, Rousselet MC, Calès P. Moal F, et al. World J Gastroenterol. 2006 Nov 7;12(41):6639-45. doi: 10.3748/wjg.v12.i41.6639. World J Gastroenterol. 2006. PMID: 17075977 Free PMC article.
Murine study of portal hypertension associated endothelin-1 hypo-response.
Theodorakis N, Maluccio M, Skill N. Theodorakis N, et al. World J Gastroenterol. 2015 Apr 28;21(16):4817-28. doi: 10.3748/wjg.v21.i16.4817. World J Gastroenterol. 2015. PMID: 25944995 Free PMC article.
Clinical pharmacokinetics in patients with liver disease.
McLean AJ, Morgan DJ. McLean AJ, et al. Clin Pharmacokinet. 1991 Jul;21(1):42-69. doi: 10.2165/00003088-199121010-00004. Clin Pharmacokinet. 1991. PMID: 1914341 Review.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wiley